España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ProQR Therapeutics
PRQR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.63
0.04
1.54%
At close: -
$2.71
0.08
3.10%
After Hours: Dec 19, 7:32 PM EDT
Get Report
Comment
ProQR Therapeutics (PRQR) Forecast
News
Earnings
ProQR Therapeutics (PRQR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ProQR Therapeutics (NASDAQ:PRQR) Stock
ProQR Therapeutics Stock (NASDAQ: PRQR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 12, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Chardan Capital Maintains Buy on ProQR Therap...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ProQR T...
Benzinga Newsdesk
Wednesday, December 11, 2024
ProQR Receives $9.1M to Develop RNA Therapy f...
Benzinga Newsdesk
Monday, November 18, 2024
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Friday, November 08, 2024
ProQR Therapeutics shares are trading higher ...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on ProQR Th...
Benzinga Newsdesk
Tuesday, October 29, 2024
This First Solar Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Avi Kapoor
Raymond James Upgrades ProQR Therapeutics to ...
Benzinga Newsdesk
Wednesday, October 23, 2024
Reported Earlier, ProQR Secures $75M Through ...
Benzinga Newsdesk
Tuesday, October 22, 2024
ProQR Therapeutics Commences Public Offering ...
Benzinga Newsdesk
Thursday, October 17, 2024
CSX Posts Weak Earnings, Joins Lucid Group, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, August 08, 2024
Pro QR Therapeutics shares are trading higher...
Benzinga Newsdesk
ProQR Therapeutics Q1 2024 GAAP EPS €(0.03) B...
Benzinga Newsdesk
Tuesday, June 18, 2024
ProQR Presents Its Axiomer RNA Editing Techno...
Benzinga Newsdesk
Friday, May 10, 2024
Chardan Capital Maintains Buy on ProQR Therap...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ProQR T...
Benzinga Newsdesk
Thursday, May 09, 2024
ProQR Therapeutics' Cash And Cash Equivalents...
Benzinga Newsdesk
ProQR Therapeutics Q1 2024 GAAP EPS €(0.09) M...
Benzinga Newsdesk
Wednesday, May 08, 2024
ProQR Gives Preclinical Proof Of Concept Data...
Benzinga Newsdesk
Monday, April 22, 2024
ProQR Therapeutics To Present On Axiomer RNA ...
Benzinga Newsdesk
Friday, April 19, 2024
ProQR Therapeutics Says It Achieved Successfu...
Benzinga Newsdesk
Thursday, March 14, 2024
HC Wainwright & Co. Reiterates Buy on ProQR T...
Benzinga Newsdesk
Chardan Capital Maintains Buy on ProQR Therap...
Benzinga Newsdesk
Wednesday, March 13, 2024
ProQR Therapeutics shares are trading higher ...
Benzinga Newsdesk
ProQR Therapeutics' 2023 Cash And Cash Equiva...
Benzinga Newsdesk
ProQR Therapeutics FY EPS $(0.38) Up From $(0...
Benzinga Newsdesk
Thursday, February 15, 2024
ProQR Says Japanese Axiomer Patent Upheld Fol...
Benzinga Newsdesk
Friday, January 19, 2024
ProQR Therapeutics Highlights New Platform Da...
Benzinga Newsdesk
ProQR Highlights New Platform Data from Prese...
Benzinga Newsdesk
Thursday, January 18, 2024
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Wednesday, January 17, 2024
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Friday, January 05, 2024
ProQR Therapeutics And Rett Syndrome Research...
Benzinga Newsdesk
Friday, December 08, 2023
ProQR Therapeutics Divested Its Ophthalmic As...
Benzinga Newsdesk
Monday, November 27, 2023
US Stocks Lower; Dow Falls Over 50 Points
Lisa Levin
Wednesday, November 08, 2023
Bluebird Bio To Rally Around 267%? Here Are 10 Top Analyst Forecasts For Wednesday
Lisa Levin
Raymond James Maintains Outperform on ProQR T...
Benzinga Newsdesk
Chardan Capital Upgrades ProQR Therapeutics t...
Benzinga Newsdesk
Monday, September 18, 2023
Citigroup Maintains Buy on ProQR Therapeutics...
Benzinga Newsdesk
Monday, August 07, 2023
HC Wainwright & Co. Reiterates Buy on ProQR T...
Benzinga Newsdesk
Friday, August 04, 2023
4 Analysts Have This to Say About ProQR Therapeutics
Benzinga Insights
Chardan Capital Reiterates Neutral on ProQR T...
Benzinga Newsdesk
Wednesday, May 17, 2023
Cantor Fitzgerald Maintains Overweight on Pro...
Benzinga Newsdesk
Analyst Ratings for ProQR Therapeutics
Benzinga Insights
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ProQR T...
Benzinga Newsdesk
Tuesday, May 16, 2023
Recap: ProQR Therapeutics Q1 Earnings
Benzinga Insights
ProQR Therapeutics Q1 EPS $(0.12) Beats $(0.1...
Benzinga Newsdesk
Thursday, March 30, 2023
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Show More
